We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

4 hedge funds and large institutions have $81.1K invested in Quoin Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more capital invested

Capital invested by funds: $52K → $81.1K (+$29K)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

33% more funds holding

Funds holding: 3 → 4 (+1)

0.68% more ownership

Funds ownership: 0.76% → 1.44% (+0.68%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$172K
2
Renaissance Technologies
Renaissance Technologies
New York
+$16.1K
3
UBS Group
UBS Group
Switzerland
+$7.81K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$31.1K
2
Citadel Advisors
Citadel Advisors
Florida
-$15.1K
3
ASN
Advisory Services Network
Georgia
-$2.44K
4
Morgan Stanley
Morgan Stanley
New York
-$111

QNRX Hedge Fund Activity: Q1 2023 in Review

4 of the 6,285 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q1 2023, worth a combined $81.1K — up 56% from $52K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new QNRX positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $172K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $31.1K sold.

  • 4 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q1 2023, up from 3 in Q4 2022.
  • Funds reported $81.1K of Quoin Pharmaceuticals stock for Q1 2023, up 56% quarter-over-quarter.
  • 3 funds opened new Quoin Pharmaceuticals positions in Q1 2023 and 2 closed out, a net change of +1 holder.
  • The largest Quoin Pharmaceuticals buyer in Q1 2023 was Virtu Financial, an estimated $172K added.
  • The largest Quoin Pharmaceuticals seller in Q1 2023 was Susquehanna International Group, an estimated $31.1K sold.

Based on aggregated 13F filings for Q1 2023.